Patents by Inventor Séverine Amand

Séverine Amand has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Purine derivative for use in the treatment or prevention of diseases caused by a nonsense mutation
    Patent number: 11179398
    Abstract: The present disclosure relates to 2,6-diaminopurine (DAP) for use in the treatment of a disease caused by a nonsense mutation in a gene, leading to the premature insertion of a UGA stop codon.
    Type: Grant
    Filed: October 20, 2017
    Date of Patent: November 23, 2021
    Assignees: MUSÉUM NATIONAL D'HISTOIRE NATURELLE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITÉ LILLE 1, SCIENCES ET TECHNOLOGIES CITÉ SCIENTIFIQUE
    Inventors: Sylvie Rebuffat, Christine Maulay-Bailly, Séverine Amand, Fabrice Lejeune
  • PURINE DERIVATIVE FOR USE IN THE TREATMENT OR PREVENTION OF DISEASES CAUSED BY A NONSENSE MUTATION
    Publication number: 20190240228
    Abstract: The present disclosure relates to 2,6-diaminopurine (DAP) for use in the treatment of a disease caused by a nonsense mutation in a gene, leading to the premature insertion of a UGA stop codon.
    Type: Application
    Filed: October 20, 2017
    Publication date: August 8, 2019
    Applicants: MUSÉUM NATIONAL D'HISTOIRE NATURELLE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITÉ LILLE 1, SCIENCES ET TECHNOLOGIES
    Inventors: Sylvie Rebuffat, Christine Maulay-Bailly, Séverine Amand, Fabrice Lejeune